Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly : A Secondary Analysis of the Aspirin in Reducing Events in the Elderly Trial.
Zoe K McQuiltenLe Thi Phuong ThaoSant-Rayn PasrichaAndrew S ArtzMichael BaileyAndrew T ChanHarvey Jay CohenJessica E LockeryAnne M MurrayMark Raymond NelsonHans-Gerhard SchneiderRory WolfeRobyn L WoodsErica Michelle WoodJohn J McNeillPublished in: Annals of internal medicine (2023)
National Institutes of Health and Australian National Health and Medical Research Council.
Keyphrases
- low dose
- healthcare
- middle aged
- phase iii
- high dose
- community dwelling
- public health
- chronic kidney disease
- clinical trial
- study protocol
- risk factors
- antiplatelet therapy
- quality improvement
- cardiovascular events
- phase ii
- type diabetes
- health information
- cardiovascular disease
- health promotion
- open label
- placebo controlled
- social media
- climate change
- acute coronary syndrome
- risk assessment